Illumina Ventures visions is to improve human health by unlocking the power of the genome.
Illumina Ventures is an independently managed venture fund in a strategic partnership with Illumina. Illumina provides the majority of their capital and access to the expertise and vision of the world's leading genomics solutions provider.They invest primarily in early stage companies, in areas where their expertise and special relationship with Illumina can add value. They typically syndicate with other leading institutional and strategic investors.Focus areas include applications of genomics in life science research, healthcare, agriculture and environmental science, public safety and personal wellness.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 19, 2022
Protillion Biosciences
|
Series A | $18M | Biopharma | Yes |
Dec 5, 2022
SonoThera
|
Series A | $60.75M | Biopharma | — |
Mar 8, 2022
Sherlock Biosciences
|
Series B | $80M | Biotechnology | — |
May 18, 2020
SQZ Biotech
|
Series D | $65M | Biotechnology | — |
Aug 8, 2018
SQZ Biotech
|
Series C | $72M | Biotechnology | — |